Protein aggregates, damaged organelles, and invading bacteria are identified and removed in healthy cells. An international ...

The FDA granted fast track status to VectorY’s VTx-002, an antibody gene therapy targeting TDP-43 protein aggregates in ALS.

Researchers headed by a team at the Centre for Genomic Regulation, Barcelona Institute of Science and Technology and at the Wellcome Sanger Institute have developed an AI tool that they say has made a ...

Researchers at the VIB-KU Leuven Center for Microbiology and the VIB-KU Leuven Center for Brain & Disease Research revealed a mechanism involving protein aggregation that allows bacteria to enter a ...

A research group led by Professor Michael Glickman, dean of Technion's Faculty of Biology, has uncovered a key mechanism in ...

Explore why tau still lacks treatments despite its critical role in Alzheimer's disease and other tauopathies.

A new large-scale study has mapped the first molecular events that drive the formation of harmful amyloid protein aggregates found in Alzheimer's disease, pointing towards a new potential therapeutic ...

When it comes to neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) and certain forms of dementia, ...

The pathway leading to the telltale sign of ALS, protein aggregation in the cytoplasm of motor neurons, has been revealed. Researchers from the University of California – San Diego (CA, USA) have ...

The new treatment leverages peptide-brush polymers, which act as a shield to prevent proteins from binding to one another. Polymer backbone is shown in yellow. Active peptides are in blue and green.